Mallosa, Ben .

HRN: 28-83-64  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/17/2026
TENOFOVIR DISOPROXIL FUMARATE 300MG TAB
04/17/2026
04/23/2026
ORAL
300mg
OD
Hep B Infection
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Disseminated Systemic Infection    Compliance to guidelines: Compliant To Guidelines